Healthcare reality of the treatment of the high-risk multiple myeloma in Spain

被引：2
|
作者：
Hernandez-Rivas, Jose-Angel [1 ,2 ]
Gironella Mesa, Mercedes [3 ,4 ]
机构：
[1] Hosp Univ Infanta Leonor, Serv Hematol & Hemoterapia, Madrid, Spain
[2] Univ Complutense Madrid, Dept Med, Madrid, Spain
[3] Hosp Univ Vail dHebron, Serv Hematol, Barcelona, Spain
[4] Univ Autonoma Barcelona, Dept Med, Barcelona, Spain
来源：
MEDICINA CLINICA | 2020年 / 154卷 / 08期
关键词：
LENALIDOMIDE PLUS DEXAMETHASONE; TREATMENT STRATEGIES; CONSENSUS; STRATIFICATION; CARFILZOMIB; GUIDELINES; MANAGEMENT; SURVIVAL;
D O I：
10.1016/j.medcli.2019.10.006
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：315 / 319
页数：5
相关论文
共 50 条
  • [21] Current Review on High-Risk Multiple Myeloma
    Henry S. H. Chan
    Christine I. Chen
    Donna E. Reece
    Current Hematologic Malignancy Reports, 2017, 12 : 96 - 108
  • [22] A High-Risk Survival Classifier for Multiple Myeloma
    Kuiper, Rowan
    Broyl, Annemiek
    de Knegt, Yvonne
    van Vliet, Martin H.
    van Beers, Erik H.
    van der Holt, Bronno
    el Jarari, Laila
    Mulligan, George
    Morgan, Gareth
    Gregory, Walter M.
    Goldschmidt, Hartmut
    Lokhorst, Henk M.
    van Duin, Mark
    Sonneveld, Pieter
    BLOOD, 2011, 118 (21) : 786 - 786
  • [23] A HIGH-RISK SURVIVAL SIGNATURE FOR MULTIPLE MYELOMA
    Kuiper, R.
    Broyl, A.
    de Knegt, Y.
    van Vliet, M.
    van Beers, E.
    van der Holt, B.
    el Jarari, L.
    Mulligan, G.
    Gregory, W.
    Morgan, G.
    Goldschmidt, H.
    Lokhorst, H.
    van Duin, M.
    Sonneveld, P.
    HAEMATOLOGICA, 2012, 97 : 223 - 223
  • [24] High-risk Multiple Myeloma: Definition and Management
    Joseph, Nisha S.
    Gentili, Silvia
    Kaufman, Jonathan L.
    Lonial, Sagar
    Nooka, Ajay K.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 : S80 - S87
  • [25] Defining and treating high-risk multiple myeloma
    S Z Usmani
    P Rodriguez-Otero
    M Bhutani
    M-V Mateos
    J S Miguel
    Leukemia, 2015, 29 : 2119 - 2125
  • [26] CAR T-cell treatment of high-risk multiple myeloma: will there be a cure?
    Gahrton, Gosta
    HAEMATOLOGICA, 2023, 108 (10) : 2568 - 2569
  • [27] Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy
    Schecter, Jordan
    Lentzsch, Suzanne
    CURRENT HEMATOLOGIC MALIGNANCY REPORTS, 2013, 8 (04) : 277 - 283
  • [28] Best Treatment Strategies in High-Risk Multiple Myeloma: Navigating a Gray Area
    Bianchi, Giada
    Richardson, Paul G.
    Anderson, Kenneth C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (20) : 2125 - 2132
  • [29] Multiple Myeloma: Defining the High-Risk Patient and Determining the Optimal Treatment Strategy
    Jordan Schecter
    Suzanne Lentzsch
    Current Hematologic Malignancy Reports, 2013, 8 : 277 - 283
  • [30] Current approaches to management of high-risk multiple myeloma
    Goldman-Mazur, Sarah
    Kumar, Shaji K.
    AMERICAN JOURNAL OF HEMATOLOGY, 2021, 96 (07) : 854 - 871
12345